Study memory changes during chemotherapy for colorectal cancer
Part of Cancer, Digestive system, Mental health clinical trials.
This study looks at cognitive (thinking and memory) changes in people with colorectal cancer who start certain chemotherapy drugs. It aims to understand how treatment affects the brain and may guide better monitoring or support during care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign informed consent and agree to be screened for the study
- You have confirmed colorectal cancer (proved by pathology/biopsy)
- You are about to start specific chemo drugs: capecitabine, oxaliplatin, 5-fluorouracil, or irinotecan
- You have NOT had any cancer chemotherapy before joining the study
- You are able to complete thinking/memory questionnaires and follow study steps
- You do not have brain metastases and have no history of certain brain/nerve disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how chemotherapy may affect memory and thinking, using thinking tests and possibly brain imaging. It compares older breast cancer patients who do and do not get chemotherapy, plus a group of healthy older adults.
This study checks how breast cancer affects memory and thinking before other treatments start. It may help doctors better understand cognitive changes and who is most at risk.
This study looks at how thinking and memory may change in children and young adults after a new cancer diagnosis, especially around chemotherapy. It may help doctors better understand and track brain-related side effects early.
This study looks at memory and thinking problems in women who have finished treatment for hormone-positive breast cancer. The goal is to find ways to help with these issues.
This study looks at how chemotherapy given before surgery for ovarian cancer may affect thinking and memory. It helps doctors understand the cognitive side effects of treatment so they can better support patients.
This study follows older women with newly diagnosed breast cancer to see who might develop thinking or memory problems over time. It may help researchers understand early brain risk and how treatment and other factors relate to cognitive decline.
Hear when a new Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.